- Home
- BW vs SCPH Comparison
BW vs SCPH Comparison
Compare BW & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BW
- SCPH
- Stock Information
- Founded
- BW 1867
- SCPH 2013
- Country
- BW United States
- SCPH United States
- Employees
- BW N/A
- SCPH 96
- Industry
- BW Building Products
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- BW Industrials
- SCPH Health Care
- Exchange
- BW Nasdaq
- SCPH Nasdaq
- Market Cap
- BW 182.0M
- SCPH 160.6M
- IPO Year
- BW N/A
- SCPH 2017
- Fundamental
- Price
- BW $1.54
- SCPH $3.28
- Analyst Decision
- BW Strong Buy
- SCPH Strong Buy
- Analyst Count
- BW 3
- SCPH 2
- Target Price
- BW $4.50
- SCPH $15.00
- AVG Volume (30 Days)
- BW 1.3M
- SCPH 427.9K
- Earning Date
- BW 03-13-2025
- SCPH 03-12-2025
- Dividend Yield
- BW N/A
- SCPH N/A
- EPS Growth
- BW N/A
- SCPH N/A
- EPS
- BW N/A
- SCPH N/A
- Revenue
- BW $878,224,000.00
- SCPH $30,278,000.00
- Revenue This Year
- BW N/A
- SCPH $172.64
- Revenue Next Year
- BW N/A
- SCPH $131.43
- P/E Ratio
- BW N/A
- SCPH N/A
- Revenue Growth
- BW N/A
- SCPH 303.87
- 52 Week Low
- BW $0.75
- SCPH $3.08
- 52 Week High
- BW $2.99
- SCPH $6.54
- Technical
- Relative Strength Index (RSI)
- BW 40.14
- SCPH 37.21
- Support Level
- BW $1.60
- SCPH $3.13
- Resistance Level
- BW $1.67
- SCPH $3.59
- Average True Range (ATR)
- BW 0.10
- SCPH 0.19
- MACD
- BW 0.00
- SCPH -0.03
- Stochastic Oscillator
- BW 17.58
- SCPH 4.84
About BW Babcock & Wilcox Enterprises Inc.
Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.